Track topics on Twitter Track topics that are important to you
The European Commission has approved apixaban (Eliquis), developed by Pfizer and Bristol-Myers Squibb, for the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip or knee replacement surgery, according to a press release. The two New York companies have an alliance to develop the drug, which is a new oral direct [...]
Original Article: Pfizer and BMS Score Approval for Orthopedic DrugNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...